UroToday - Overactive Bladder (OAB)

Home

Overactive Bladder (OAB)

Overactive Bladder

UroToday's Overactive Bladder section is a repository of the clinical publications, clinical trials and investigative science pertaining to the diagnosis and treatment of overactive bladder. Also available are conference coverage for all timely overactive bladder science, audio podcasts and downloadable slides from UroToday's slide library.

Online Urology & Urologic Oncology Journal
Please read about the UroToday International Journal; We welcome submissions year round and are committed to providing fast-tracked, peer reviewed publication.
Kind regards,
Christian Gratzke, MD
Associate Section Editor Overactive Bladder
UroToday International Journal

Display

results per page

Results 226 - 240 of 311

<< Start < Prev 11 12 13 14 15 16 17 18 19 20 Next > End >>

SUFU 2007 - Effects of Prior Therapy on Health-Related Quality of Life Following Treatment with Transdermal Oxybutynin
Thursday, 22 March 2007

read more

SUFU 2007 - A New Overactive Bladder Questionnaire & Severity Score
Wednesday, 21 March 2007
read more

SUFU 2007 - Once-Daily Trospium Chloride Extended Release Is Effective and Well Tolerated for the Treatment of Overactive Bladder: Results from a Multicenter, Phase III Trial
Tuesday, 20 March 2007
read more

SUFU 2007 - The Evolution of Obstruction-Induced Overactive Bladder (OAB) Symptoms Following Urethrolysis for Female Bladder Outlet Obstruction
Monday, 19 March 2007
read more

Overactive Bladder Syndrome in Older People
Wednesday, 07 March 2007
BJUI Mini Reviews - March 2007 Overactive Bladder Syndrome in Older People
read more

European Urology - Relaxation of Phasic Contractile Activity of Human Detrusor Strips by Cyclic Nucleotide Phosphodiesterase Type 4 Inhibition
Thursday, 01 March 2007
Volume 51, Issue 3, Pages 772-781 (March 2007) Abstract - Objectives: Detrusor smooth muscle relaxation is mainly mediated by the cyclic adenosine monophosphate (cAMP) pathway.
read more

SUFU 2007 - Trospium Chloride Extended-Release Formulation Provides Effective Relief for the Symptoms of Overactive Bladder, Improves Patient-Reported Quality of Life, and Is Well Tolerated: Results from a Multicenter, Phase III, Placebo-Controlled Study
Thursday, 01 March 2007
read more

SUFU 2007 - Botox™ Repeated Injections: Side Effects and Complications
Thursday, 01 March 2007
read more

SUFU 2007 - Initial Evaluation of the Effect of Injection Volumes of Intravesical Botulinum-A Toxin Injections in Patients with Overactive Bladder Symptoms
Thursday, 01 March 2007
read more

SUFU 2007 - Scheduled Repeated BOTOX™ Injections for Idiopathic OAB: Evaluating Therapeutic Time
Thursday, 01 March 2007
read more

SUFU 2007 - Tolterodine Does Not Affect Memory Assessed By Passive-Avoidance Test in Mice
Thursday, 01 March 2007
read more

SUFU 2007 - A Comparison of the Pharmacokinetics of Once-Daily Trospium Chloride Extended Release 60 Mg in Fasted, Fasted With Antacid, and High-Fat Meal Conditions
Thursday, 01 March 2007
read more

SUFU 2007 - Using Caveolin-1 Knockout Mouse to Study Impaired Detrusor Contractility and Disrupted Muscarinic Activity in the Aging Bladder
Thursday, 01 March 2007
read more

SUFU 2007 - Effects of an Antiepileptic -Levetiracetam (KEPPRA®), on Neurogenic Overactive Bladder in Chronic Paraplegic Rats
Thursday, 01 March 2007
read more

SUFU 2007 - Calcitonin Gene-Related Peptide Release Is Not Inhibited by Anticholinergics in Acute Injury Rat Bladder Model
Thursday, 01 March 2007
read more

Focus on Overactive Bladder

CME Activity

Overactive Bladder Management: Thinking Beyond Urgency and Frequency

New: Poster Presentation
Clinical Proof of Concept Study (BLOSSOM) Shows Novel Beta 3 Adrenoceptor Agonist YM178 is Effective and Well Tolerated in the Treatment of Symptoms of Overactive Bladder

Review
Defining Overactive Bladder as Hypersensitivity

Review
Lower Urinary Tract Symptomatology: Its Definition and Confusion

Review
Overlap of Voiding Symptoms, Storage Symptoms and Pain in Men and Women

Review
Resiniferatoxin and Botulinum Toxin Type A for Treatment of Lower Urinary Tract Symptoms

Abstract
Anticholinergic Drugs Versus Other Medications for Overactive Bladder Syndrome in Adults

Abstract
Long-Term Darifenacin Treatment for Overactive Bladder in Patients Aged 65 Years and Older: Analysis of Results from a 2-Year, Open-Label Extension Study

Overactive Bladder Viewpoints

BJU Int Mini Reviews

- Sacral Neuromodulation for Treating the Symptoms of Overactive Bladder Syndrome and Non-Obstructive Urinary Retention: More Than 10 Years of Clinical Experience

- View

BJU Int Mini Reviews

- Treating Patients with Overactive Bladder Syndrome with Antimuscarinics: Heart Rate Considerations

- View